RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo battles Tough-to-Treat lymphoma in major trial
Disease control OngoingThis study is testing whether a new two-drug combination (loncastuximab tesirine plus rituximab) works better and is safer than standard immunochemotherapy for adults with an aggressive type of lymphoma that has come back or hasn't responded to prior treatment. It will involve ab…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE3 • Sponsor: ADC Therapeutics S.A. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Major trial tests new drug combo for Tough-to-Treat blood cancer
Disease control OngoingThis large, international Phase 3 study is testing whether adding a newer drug called polatuzumab vedotin to a standard chemotherapy combination (R-ICE) works better for controlling aggressive lymphoma that has come back or didn't respond to first treatment. About 306 adults with…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE3 • Sponsor: GWT-TUD GmbH • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Scientists test new drug duo in fight against Tough-to-Treat blood cancer
Disease control OngoingThis study is testing whether combining two existing cancer drugs, copanlisib and venetoclax, can help control an aggressive type of lymphoma called DLBCL that has returned or stopped responding to other treatments. The first part of the study aims to find a safe dose, and the se…
Matched conditions: RELAPSED DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC